SITC Primer on Tumor Immunology and Cancer Immunotherapy

Understanding of tumor immunobiology has increased dramatically in recent years, leading to the successful development of new immune-based treatment options to improve cancer outcomes. The SITC Primer on Tumor Immunology and Cancer Immunotherapy™ is designed to provide a foundation for understanding core immunology principles as they relate to basic and clinical research in immunotherapy of cancer. Prominent investigators will summarize central themes and recent research in tumor immunology and cancer immunotherapy.

Topics Addressed
• Approved Therapies
• Basic Tumor Immunology
• Immune Monitoring Strategies
• Obstacles to Cancer Immunotherapy

Session Topics
• Adaptive Immunity
• Anti-Tumor Antibodies
• Cancer Vaccines
• Dendritic Cells
• Immune Checkpoint Blockade
• Innate Immunity
• Monitoring T and B Cell Response
• Obstacles to Driving an Immune Response
• Pre-Surgical Clinical Trial Design For Immune Monitoring

The SITC Primer on Tumor Immunology and Cancer Immunotherapy™ is a part of SITC 2013. This five-day event offers the latest, most relevant research, educational sessions, and networking opportunities in a variety of formats, including the SITC Workshop on Personalized Cancer Immunotherapy which will also take place on November 7, and the SITC 28th Annual Meeting which will take place November 8-10. Abstract submission, registration and housing for SITC 2013 will open May 1 on the SITC 2013 meeting website -

+ show speakers and program
• Charles G. Drake, MD, PhD - Johns Hopkins University
• Padmanee Sharma, MD, PhD - MD Anderson Cancer Center

7 Nov - 7 Nov 2013

National Harbor
United States of America
meeting website